Clinical Trials
3
Active:1
Completed:1
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by Lumpectomy
Not Applicable
Recruiting
- Conditions
- Mastectomy, SegmentalBreast Neoplasm Malignant Female
- First Posted Date
- 2023-07-12
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Tensive SRL
- Target Recruit Count
- 92
- Registration Number
- NCT05941299
- Locations
- 🇮🇹
IEO Istituto Europeo di Oncologia, Milan, Italy
🇮🇹A.O.U. Pisana - Ospedale Santa Chiara, Pisa, Italy
🇪🇸Complejo Hospitalario Universitario A Coruña, A Coruña, Spain
REGENERA Implant in Localized Non-malignant Breast Lesions Treated by Excision or Lumpectomy - Long-term Follow-up
Active, not recruiting
- Conditions
- Breast Diseases
- First Posted Date
- 2022-09-08
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Tensive SRL
- Target Recruit Count
- 14
- Registration Number
- NCT05533099
- Locations
- 🇮🇹
Unità Operativa di Senologia (Breast Surgery Unit), Ospedale Santa Chiara, Pisa, Italy
REGENERA Implant in Excised Non-Malignant Breast Lesions
Not Applicable
Completed
- Conditions
- Benign Breast Disease
- First Posted Date
- 2019-10-18
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- Tensive SRL
- Target Recruit Count
- 15
- Registration Number
- NCT04131972
- Locations
- 🇮🇹
Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
News
No news found